Physician-led weight loss that slashes GLP-1 costs

telehealth glp-1 weight loss with a real doctor

Personalized, response-driven treatment from a board-certified physician—with no membership fees or prepaid dosing packages.

Get started
See how it works
GLP-1 weight loss with a real doctor in texas
GLP-1 weight loss with a real doctor in texas
GLP-1 weight loss with a real doctor in texas
Digital infographic showing a 62.8% reduction in sleep apnea severity with a graphical depiction of a crescent moon and a wavy line.

Real Doctors

Every appointment is with a board-certified physician

Dosing based on your response—not a preset schedule

Lowest Effective Dose

Ongoing guidance and personalized adjustments

Support

Book Appointment
Affordable GLP-1 options in texas

Made For You.

More than a prescription.

Everything is done virtually for convenience—but your care is anything but simplified.

You’ll meet directly with a doctor, receive individualized guidance, and follow a structured, evidence-based approach to weight management.

If appropriate, medications can be prescribed and delivered to your door with ongoing support to ensure they’re used effectively.

  • physician-led care—not automated or one-size-fits-all

  • evidence-based treatment plans tailored to your goals

  • ongoing guidance to maximize results and minimize side effects

  • streamlined virtual care designed to fit your life

Recurring monthly membership.

No memberships—pay as you go.

The SonaWell Approach

Typical GLP-1 Program

Click and ship.

Real doctors appointments.

Comprehensive weight-management care.

Medication-centered.

Standardized dose-escalation schedules.

Stay at the lowest effective dose.

Side effects expected.

Frequent monitoring and early adjustments.

Medicare GLP-1 coverage is finally here - but there are a few important rules people need to know before they get excited. Starting today, some Medicare beneficiaries may be able to access certain weight loss medications for a lower monthly cost, bu

  • “Dr. Toufexis is an exceptional doctor: knowledgeable, kind, and truly attentive. She takes the time to listen to my concerns and explain everything clearly. I felt cared for and never rushed. Highly recommend!”

    —IS

  • “Dr. Toufexis is so kind and attentive. She took the time to listen and explain everything, which really put me at ease. Thanks to her for making my visit such a positive experience!”

    —NP

  • “Dr Toufexis is caring passionate and very knowledgable at what she does! I felt listened to cared for and had all of my questions answered. Thanks Dr. Toufexis and to the SonaWell team!”

    —KR

Dr. Andi is a weight loss doctor specializing in individualized GLP-1 weight management programs

Dr. Andi Toufexis, founder

Dr. Toufexis is a board-certified Family Medicine physician, U.S. Army veteran, and devoted mom who brings both expertise and heart to every patient she serves. She trained extensively in primary care and preventive medicine and is nationally certified in patient safety, bringing hospital-level standards into every consultation and treatment.

With a background that blends rigorous medical training, military discipline, and the real-life perspective of motherhood, Dr. Toufexis understands that true wellness is both personal and holistic. She is committed to creating a concierge experience that is not only safe and effective but also deeply tailored to each individual.

Get Started with Dr. Andi 
Research context: The 16.7% average weight loss shown was observed at 64 weeks in the TRIM real-world study of 2,694 participants receiving personalized semaglutide dosing with behavioral support. In separate randomized trials, semaglutide 2.4 mg reduced the relative risk of major cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease without diabetes (SELECT); tirzepatide reduced the relative risk of progression to type 2 diabetes by 93% over 176 weeks in adults with obesity and prediabetes (SURMOUNT-1); and tirzepatide reduced sleep-apnea severity by up to 62.8% at 52 weeks in adults with obesity and moderate-to-severe obstructive sleep apnea (SURMOUNT-OSA). These findings come from different study populations, medications, doses, and treatment protocols and are provided for educational purposes. They are not results from SonaWell patients or guarantees of individual outcomes. Eligibility, treatment response, risks, and benefits vary by patient.